IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Werner Skuballa

USPTO Granted Patents = 106 

Average Co-Inventor Count = 5.3

ph-index = 13

Forward Citations = 538(Granted Patents)


Inventors with similar research interests:


Company Filing History:

goldMedal91 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal10 out of 192 
 
Bayer Schering Pharma Ag
 patents
bronzeMedal1 out of 1 
 
Schering Aktiengesellschft
 patent
4. 1 out of 1 
 
Schering Aktiengesellschaft Patents
 patent
5. 1 out of 1 
 
Schering Aktiengeselleschaft
 patent
6. 1 out of 378 
 
Bayer Pharma Aktiengesellschaft
 patents
7. 1 out of 1 
 
Schering Aktiengesellscaft
 patent

Years Active: 1976-2012

Loading Chart...
106 patents (USPTO):Explore Patents
1. 8097627 - Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents (2012-01-17),
2. 7935827 - Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters (2011-05-03),
3. 7928255 - [object Object] (2011-04-19),
4. 7776896 - 5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection (2010-08-17),
5. 7700621 - 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations (2010-04-20),
6. 7662821 - Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents (2010-02-16),
7. 7659297 - Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents (2010-02-09),
8. 7645891 - 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations (2010-01-12),
9. 7638515 - Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents (2009-12-29),
10. 7626035 - Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters (2009-12-01),
11. 7563924 - 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments (2009-07-21),
12. 7442794 - Rearranged pentanols, a process for their production and their use as anti-inflammatory agents (2008-10-28),
13. 7417056 - 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents (2008-08-26),
14. 7407975 - Epothilone derivatives, method for producing same and their pharmaceutical use (2008-08-05),
15. 7329753 - Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors (2008-02-12),

Certainly, I can help with that. Here is the article about inventor Werner Skuballa:

Title: The Inventive Journey of Werner Skuballa: Pioneering Innovations in Berlin

Introduction:

Werner Skuballa, a prolific inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals with his numerous patented inventions. With a total of 106 patents to his name, Skuballa's innovative spirit and dedication to advancing anti-inflammatory agents have solidified his position as a trailblazer in the industry.

Latest Patents:

1. Multiply-substituted tetrahydronaphthalene derivatives: Skuballa's invention of multiply-substituted tetrahydronaphthalene derivatives of formula (I) showcases his expertise in developing novel compounds for anti-inflammatory purposes.

2. Optically active, heteroaromatic β-hydroxy esters: Skuballa's groundbreaking work on optically active heteroaromatic β-hydroxy esters has paved the way for the synthesis of epothilone derivatives, demonstrating his commitment to pushing the boundaries of pharmaceutical innovation.

Career Highlights:

Skuballa's illustrious career includes stints at reputable pharmaceutical companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His tenure at these organizations provided him with valuable industry experience and a platform to transform his inventive ideas into tangible innovations that have had a profound impact on the healthcare landscape.

Collaborations:

Throughout his career, Skuballa has collaborated with esteemed professionals in the field, including Helmut Vorbrueggen and Bernd Buchmann. Together, these visionaries have worked tirelessly to develop cutting-edge pharmaceutical solutions that address complex medical needs and improve patient outcomes.

Conclusion:

In conclusion, Werner Skuballa's impressive portfolio of patents and his dedication to advancing the field of anti-inflammatory agents underscore his status as a pioneering inventor in the pharmaceutical industry. His innovative spirit, coupled with his collaborative efforts and industry expertise, continues to shape the future of healthcare and inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…